| Mr Jason Davis, DO | |
|
3940 N Marquette St, Davenport, IA 52806-4430 | |
| (563) 386-3111 | |
| (563) 386-3113 |
| Full Name | Mr Jason Davis |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 24 Years |
| Location | 3940 N Marquette St, Davenport, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588662050 | NPI | - | NPPES |
| 34933 | Other | IA | BCBS OF IOWA |
| 4261008 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | IA3392 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Vna | Bettendorf, IA | Home health agency |
| Genesis Medical Center-davenport | Davenport, IA | Hospital |
| Genesis Hlth System Dba Genesis Mdl Ctr-illini | Silvis, IL | Hospital |
| Trinity Muscatine | Muscatine, IA | Hospital |
| Trinity - Bettendorf | Bettendorf, IA | Hospital |
| Genesis Medical Center-dewitt | Dewitt, IA | Hospital |
| Entity Name | Genesis Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477654945 PECOS PAC ID: 7214841436 Enrollment ID: O20031113000044 |
News Archive
Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.
eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.
Scientists have what could be some very bad news for disease-causing bacteria. All three major classes of antibiotics that kill infectious bacteria do so in part by ramping up the production of harmful free radicals, researchers report in the September 7, 2007, issue of Cell, a publication of Cell Press.
The American Association for Cancer Research will recognize Philip S. Low, PhD, with the ninth annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
Saint Luke's Health System and doxo today announced Saint Luke's Health System has launched doxo across all ten of its hospitals to expand patients' electronic access to their billing information.
› Verified 5 days ago
| Entity Name | Quad City Family Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265430961 PECOS PAC ID: 5193717361 Enrollment ID: O20040330001741 |
News Archive
Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.
eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.
Scientists have what could be some very bad news for disease-causing bacteria. All three major classes of antibiotics that kill infectious bacteria do so in part by ramping up the production of harmful free radicals, researchers report in the September 7, 2007, issue of Cell, a publication of Cell Press.
The American Association for Cancer Research will recognize Philip S. Low, PhD, with the ninth annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
Saint Luke's Health System and doxo today announced Saint Luke's Health System has launched doxo across all ten of its hospitals to expand patients' electronic access to their billing information.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jason Davis, DO 3940 N Marquette St, Davenport, IA 52806-4430 Ph: (563) 386-3111 | Mr Jason Davis, DO 3940 N Marquette St, Davenport, IA 52806-4430 Ph: (563) 386-3111 |
News Archive
Trubion Pharmaceuticals, Inc. today announced favorable safety and efficacy data following administration of a second course (R2) of re-treatment with 800 mg of TRU-015 for rheumatoid arthritis (RA). These data are the latest results from the ongoing open-label re-treatment portion of the Phase 2b (15002) RA study of TRU-015. Pfizer Inc. and Trubion are collaborating on the development of TRU-015 for the treatment of autoimmune and inflammatory diseases, including RA.
eResearchTechnology, Inc. (ERT), a global technology-driven provider of health outcomes research services to biopharmaceutical sponsors and contract research organizations (CROs), today announced that it has entered into a definitive agreement to be acquired by affiliates of Genstar Capital LLC, a leading middle market private equity firm for $8.00 per share in cash in a transaction valued at approximately $400 million.
Scientists have what could be some very bad news for disease-causing bacteria. All three major classes of antibiotics that kill infectious bacteria do so in part by ramping up the production of harmful free radicals, researchers report in the September 7, 2007, issue of Cell, a publication of Cell Press.
The American Association for Cancer Research will recognize Philip S. Low, PhD, with the ninth annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research at the AACR Annual Meeting 2015, to be held in Philadelphia, April 18-22.
Saint Luke's Health System and doxo today announced Saint Luke's Health System has launched doxo across all ten of its hospitals to expand patients' electronic access to their billing information.
› Verified 5 days ago